speb/financial-data huggingface dataset:
Financial ratios for AAG.V — quarterly report dated 2025-11-30
Total revenue: 0
Gross profit: -2409.285714285714
Operating income: -2257777.142857143
Net income: -2373680.7142857146
Capital expenditures: 0
Operating cash flow: -2144115.7142857146
Depreciation & amortization: 2409.285714285714
Net tangible assets: 26248630
Owner earnings: -2371271.4285714286
Return on net tangible assets (%): -9.03388644882201
Buffett classification: The Gruesome
Stock price: 0.6214285714285714
Shares outstanding: 341631113
Book value: 26248630
P/B ratio: 8.088015812906916
Market cap (USD): 212299334.50714287
Debt to equity: 0
Current ratio: 8.209205765044556
Quick ratio: 8.209205765044556
Free cash flow (dilution-adjusted): -2280237.8571428573
Buyback yield (%): 0
Retained earnings: -44690939.28571429
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.601504698939118
Rule of 40 score: 0
Financial ratios for ARTG.V — annual report dated 2021-12-31
Operating income: -8442179.527559055
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.433070866141732
Shares outstanding: 233065546
Market cap (USD): 1266261627.8740158
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARTG.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -303127.94117647054
Operating income: -9690475.735294117
Net income: -15904347.058823528
Capital expenditures: 71260398.52941176
Operating cash flow: -4451115.44117647
Depreciation & amortization: 303127.94117647054
Net tangible assets: 424579213.9705882
Owner earnings: -86861617.64705881
Return on net tangible assets (%): -20.458283116298755
Buffett classification: The Gruesome
Stock price: 3.227941176470588
Shares outstanding: 233065546
Book value: 424579213.9705882
P/B ratio: 1.7719234668000383
Market cap (USD): 752321872.7499999
Debt to equity: 0.002965849937678175
Current ratio: 7.792353282018249
Quick ratio: 7.792353282018249
Interest coverage ratio: -181.66719966917086
Free cash flow (dilution-adjusted): -79445756.61764707
Buyback yield (%): 0
Retained earnings: -24262556.617647056
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.087066177132648
Rule of 40 score: 0
Financial ratios for ARTG.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -514679.5454545454
Operating income: -10827661.363636363
Net income: -8670553.787878787
Capital expenditures: 300321228.78787875
Operating cash flow: -6454479.545454545
Depreciation & amortization: 514679.5454545454
Net tangible assets: 440420799.24242425
Owner earnings: -308477103.030303
Return on net tangible assets (%): -70.04144753402201
Buffett classification: The Gruesome
Stock price: 4.787878787878788
Shares outstanding: 233065546
Book value: 440420799.24242425
P/B ratio: 2.5336895664288557
Market cap (USD): 1115889583.878788
Debt to equity: 0.28354221772977084
Current ratio: 2.9244680042253903
Quick ratio: 2.9244680042253903
Interest coverage ratio: -129.7243773598606
Free cash flow (dilution-adjusted): -310160005.3030303
Buyback yield (%): 0
Retained earnings: -33668339.39393939
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.3436226642826337
Rule of 40 score: 0
Financial ratios for ARTG.V — quarterly report dated 2024-09-30
Operating income: -3252974.814814815
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.607407407407408
Shares outstanding: 233065546
Market cap (USD): 2239155653.0518517
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARTG.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -12409790.209790211
Net income: -21987412.58741259
Capital expenditures: 338441958.04195803
Operating cash flow: -6161538.461538462
Depreciation & amortization: 476223.7762237762
Net tangible assets: 413183216.7832168
Owner earnings: -359953146.85314685
Return on net tangible assets (%): -87.11707838849662
Buffett classification: The Gruesome
Stock price: 9.615384615384615
Shares outstanding: 233065546
Book value: 413183216.7832167
P/B ratio: 5.4237799948210395
Market cap (USD): 2241014865.3846154
Debt to equity: 1.0325682235145182
Current ratio: 0.1722989611702735
Quick ratio: 0.1722989611702735
Interest coverage ratio: -260.97058823529414
Free cash flow (dilution-adjusted): -350196503.49650353
Buyback yield (%): 0
Retained earnings: -53065734.26573427
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.267740762516136
Rule of 40 score: 0
Financial ratios for ARTG.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -119182.51748251749
Operating income: -2719327.9720279723
Net income: -6132738.461538462
Capital expenditures: 78185586.01398602
Operating cash flow: -992013.2867132868
Depreciation & amortization: 119182.51748251749
Net tangible assets: 413183216.7832168
Owner earnings: -84199141.95804197
Return on net tangible assets (%): -20.37816119772803
Buffett classification: The Gruesome
Stock price: 9.615384615384615
Shares outstanding: 233065546
Book value: 413183216.7832167
P/B ratio: 5.4237799948210395
Market cap (USD): 2241014865.3846154
Debt to equity: 0.7609672134476994
Current ratio: 0.1722989611702735
Quick ratio: 0.1722989611702735
Interest coverage ratio: -311.88955726660254
Free cash flow (dilution-adjusted): -80416669.93006994
Buyback yield (%): 0
Retained earnings: -53065734.26573427
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.2777970343181554
Rule of 40 score: 0
Financial ratios for ARTG.V — quarterly report dated 2025-03-31
Total revenue: 28718181.81818182
Gross profit: 22271328.67132867
Operating income: 18627972.027972028
Net income: 3246153.8461538465
Capital expenditures: 63022377.62237763
Operating cash flow: 9792307.692307692
Depreciation & amortization: 119580.41958041959
Net tangible assets: 420120259.44055945
Owner earnings: -59656643.356643364
Return on net tangible assets (%): -14.199896819087787
Capex to operating income (%): 338.3211952849313
Buffett classification: The Gruesome
Stock price: 11.965034965034965
P/E ratio: 214.7647292147781
Shares outstanding: 233065546
Book value: 420120259.4405594
P/B ratio: 6.637712284450102
Market cap (USD): 2788637407.034965
Debt to equity: 1.1082502082974175
Current ratio: 0.14139517359509252
Quick ratio: 0.11910642166278448
Effective tax rate (%): 17.21062957018013
Interest coverage ratio: 2663.7999999999997
COGS to revenue (%): 22.451116468210486
SG&A to revenue (%): 11.931721333430735
Free cash flow (dilution-adjusted): -54674825.17482518
Buyback yield (%): 0
Retained earnings: -49819200.6993007
Inventory turnover: 0.9975900949907021
Receivables turnover: 14.660528810025722
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.826841280771278
FCF margin (%): -190.38400662332288
Rule of 40 score: -190.38400662332288
Financial ratios for ARTG.V — quarterly report dated 2025-06-30
Total revenue: 168659854.01459852
Gross profit: 122545255.47445254
Operating income: 118857664.23357664
Net income: 73128467.15328467
Capital expenditures: 106911678.83211678
Operating cash flow: 135137226.27737224
Depreciation & amortization: 6289051.094890511
Net tangible assets: 546144525.5474452
Owner earnings: -27494160.58394161
Return on net tangible assets (%): -5.034227992376555
Capex to operating income (%): 89.94933521663033
Buffett classification: The Gruesome
Stock price: 18.080291970802918
P/E ratio: 59.99117574533867
Shares outstanding: 233065546
Book value: 546144525.5474453
P/B ratio: 7.715710627678028
Market cap (USD): 4213893120.014598
Debt to equity: 0.8646704570058458
Current ratio: 0.2280546856677749
Quick ratio: 0.18266263835814237
Effective tax rate (%): 31.73620054100829
Interest coverage ratio: 11.657717640320735
COGS to revenue (%): 27.341775438839456
SG&A to revenue (%): 2.1180279056884674
Free cash flow (dilution-adjusted): 24188321.16788321
Buyback yield (%): 0
Retained earnings: 21127737.22627737
Inventory turnover: 3.2001316989160165
Receivables turnover: 29.692109997429966
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.293061641428382
FCF margin (%): 14.341481148080188
Revenue growth (%): 487.29293895555037
Rule of 40 score: 501.63442010363053
Financial ratios for ARTG.V — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.251798561151084
P/E ratio: 87.10458125656616
Shares outstanding: 233065546
Market cap (USD): 6118389765.136692
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARTG.V — annual report dated 2025-12-31
Total revenue: 667108759.1240876
Gross profit: 489531386.8613138
Operating income: 473808759.1240876
Net income: 254862043.7956204
Capital expenditures: 292971532.84671533
Operating cash flow: 409274452.5547445
Depreciation & amortization: 24148905.10948905
Net tangible assets: 738686861.3138685
Owner earnings: -13960583.941605866
Return on net tangible assets (%): -1.8899190811076314
Capex to operating income (%): 61.83328763029219
Buffett classification: The Good
Stock price: 26.781021897810216
P/E ratio: 24.490635789048607
Shares outstanding: 233065546
Book value: 738686861.3138685
P/B ratio: 8.449769202540313
Market cap (USD): 6241733491.051094
Debt to equity: 0.5862701716697909
Current ratio: 0.8076601342704139
Quick ratio: 0.6958896666118527
Effective tax rate (%): 34.5575487452651
Interest coverage ratio: 13.538522504484213
COGS to revenue (%): 26.618953781379282
SG&A to revenue (%): 2.1733397962008407
Free cash flow (dilution-adjusted): 103106569.34306568
Buyback yield (%): 0
Retained earnings: 199472262.77372262
Inventory turnover: 7.781008123840595
Receivables turnover: 68.67590922753232
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.63910335408911
FCF margin (%): 15.455736104926038
Rule of 40 score: 15.455736104926038
Financial ratios for ARTG.V — quarterly report dated 2025-12-31
Total revenue: 243578832.1167883
Gross profit: 174640145.98540145
Operating income: 171483211.6788321
Net income: 97429927.00729926
Capital expenditures: 69278102.18978101
Operating cash flow: 144442335.76642334
Depreciation & amortization: 9933576.642335765
Net tangible assets: 738686861.3138685
Owner earnings: 38085401.45985401
Return on net tangible assets (%): 5.15582494483701
Capex to operating income (%): 40.39934959903291
Buffett classification: The Good
Stock price: 26.781021897810216
P/E ratio: 35.912371469181146
Shares outstanding: 233065546
Book value: 738686861.3138685
P/B ratio: 8.449769202540313
Market cap (USD): 6241733491.051094
Debt to equity: 0.5862701716697909
Current ratio: 0.8076601342704139
Quick ratio: 0.6958896666118527
Effective tax rate (%): 35.74306662109403
Interest coverage ratio: 15.484576852095968
COGS to revenue (%): 28.302412624399544
SG&A to revenue (%): 1.1177604037122832
Free cash flow (dilution-adjusted): 72367883.21167883
Buyback yield (%): 0
Retained earnings: 199472262.77372262
Inventory turnover: 3.020725388601037
Receivables turnover: 25.075368199579202
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.727131013441104
FCF margin (%): 29.710251331273618
Rule of 40 score: 29.710251331273618
Financial ratios for ASML.TO — quarterly report dated 2025-12-31
Total revenue: 7093503649.6350355
Gross profit: 3699708029.19708
Operating income: 2504452554.7445254
Net income: 2072700729.9270072
Capital expenditures: 326934306.56934303
Operating cash flow: 8328686131.386861
Depreciation & amortization: 186277372.26277372
Net tangible assets: 10571897810.218977
Owner earnings: 1932043795.6204376
Return on net tangible assets (%): 18.275278765491766
Capex to operating income (%): 13.05412258459386
Buffett classification: The Great
Stock price: 21.635036496350363
P/E ratio: 54.56553859370565
Shares outstanding: 17452173502
Book value: 14315474452.554749
P/B ratio: 26.37554290692935
Market cap (USD): 377578410656.40875
Debt to equity: 0.2238861524969151
Current ratio: 1.2617963311751204
Quick ratio: 0.7907549899233018
Effective tax rate (%): 17.973447985358625
COGS to revenue (%): 47.843714306294444
R&D to revenue (%): 12.989164548625762
SG&A to revenue (%): 3.8608369948858323
Free cash flow (dilution-adjusted): 7944744525.547444
Buyback yield (%): 0.3286405889180829
Retained earnings: 12837445255.474451
Inventory turnover: 0.4068053161610947
Receivables turnover: 2.1038036066070616
Capitalized R&D asset: 1736826140.8391535
ROCI (R&D-adjusted, %): 12.27064202021574
Rosenberg metric: 1.1385353662703537
FCF margin (%): 112.00028812216381
Revenue growth (%): 31.18640331283527
Rule of 40 score: 143.1866914349991
Financial ratios for ASML.TO — annual report dated 2025-12-31
Total revenue: 23844744525.547443
Gross profit: 12597080291.970802
Operating income: 8249197080.29197
Net income: 7014160583.941606
Capital expenditures: 1148613138.6861312
Operating cash flow: 9239781021.89781
Depreciation & amortization: 748832116.7883211
Net tangible assets: 10571897810.218977
Owner earnings: 6614379562.043796
Return on net tangible assets (%): 62.56567818552147
Capex to operating income (%): 13.92393862707275
Buffett classification: The Great
Stock price: 21.635036496350363
P/E ratio: 53.830876287726596
Shares outstanding: 17452173502
Book value: 14315474452.554749
P/B ratio: 26.37554290692935
Market cap (USD): 377578410656.40875
Debt to equity: 0.2238861524969151
Current ratio: 1.2617963311751204
Quick ratio: 0.7907549899233018
Effective tax rate (%): 17.651958162737483
Interest coverage ratio: 95.53169907016061
COGS to revenue (%): 47.17041200221628
R&D to revenue (%): 14.383802763007655
SG&A to revenue (%): 3.8503335139420765
Free cash flow (dilution-adjusted): 7901459854.014598
Buyback yield (%): 1.15024206121329
Retained earnings: 12837445255.474451
Inventory turnover: 1.3482278004777195
Receivables turnover: 7.071915658216613
Capitalized R&D asset: 6441349903.016691
ROCI (R&D-adjusted, %): 33.25736703126325
Rosenberg metric: 0.8183248873105108
FCF margin (%): 33.13711264781601
Revenue growth (%): 20.645739366918615
Rule of 40 score: 53.78285201473463
Financial ratios for AUAU.V — annual report dated 2021-09-30
Capital expenditures: 1733304.6875
Buffett classification: The Gruesome
Stock price: 0.265625
Shares outstanding: 113505070
Market cap (USD): 30149784.21875
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUAU.V — annual report dated 2022-09-30
Total revenue: 0
Gross profit: -20812.408759124086
Operating income: -1891889.0510948903
Net income: -1264105.8394160583
Capital expenditures: 2918029.197080292
Operating cash flow: -711360.5839416058
Depreciation & amortization: 20812.408759124086
Net tangible assets: 23880846.715328466
Owner earnings: -4161322.627737226
Return on net tangible assets (%): -17.42535630056277
Buffett classification: The Gruesome
Stock price: 0.1386861313868613
Shares outstanding: 113505070
Book value: 23880846.715328466
P/B ratio: 0.659171730330265
Market cap (USD): 15741579.05109489
Debt to equity: 0.0018548902764210149
Current ratio: 5.423721744052088
Quick ratio: 5.423721744052088
Interest coverage ratio: -247.15247449222846
Free cash flow (dilution-adjusted): -4264128.467153285
Buyback yield (%): 0
Retained earnings: -7813364.233576641
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.8788769731937585
Rule of 40 score: 0
Financial ratios for AUAU.V — annual report dated 2023-09-30
Total revenue: 0
Gross profit: -22308.148148148146
Operating income: -1361402.962962963
Net income: 351592.5925925926
Capital expenditures: 2106693.333333333
Operating cash flow: -1282142.962962963
Depreciation & amortization: 22308.148148148146
Net tangible assets: 25017208.148148146
Owner earnings: -1732792.5925925924
Return on net tangible assets (%): -6.926402747785665
Buffett classification: The Gruesome
Stock price: 0.0962962962962963
P/E ratio: 31.08745201727589
Shares outstanding: 113505070
Book value: 25017208.148148146
P/B ratio: 0.4369039817363048
Market cap (USD): 10930117.851851853
Debt to equity: 0.0007164549936012932
Current ratio: 17.051192366708882
Quick ratio: 17.051192366708882
Interest coverage ratio: -283.9323343117565
Free cash flow (dilution-adjusted): -1713121.4814814813
Buyback yield (%): 0
Retained earnings: -7577525.185185185
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.413033410032213
Rule of 40 score: 0
Financial ratios for AUAU.V — annual report dated 2024-09-30
Total revenue: 0
Gross profit: -13087.407407407407
Operating income: -1283661.4814814813
Net income: 1116550.3703703703
Capital expenditures: 0
Operating cash flow: -952932.5925925926
Depreciation & amortization: 13087.407407407407
Net tangible assets: 26583018.518518515
Owner earnings: 1129637.7777777778
Return on net tangible assets (%): 4.249471432263566
Buffett classification: The Gruesome
Stock price: 0.14074074074074072
P/E ratio: 14.307270010873436
Shares outstanding: 113505070
Book value: 26583018.518518515
P/B ratio: 0.6009395666824338
Market cap (USD): 15974787.629629627
Debt to equity: 0.009414252903029852
Current ratio: 2.8031499592940476
Quick ratio: 2.8031499592940476
Interest coverage ratio: -4621.181333333333
Free cash flow (dilution-adjusted): -1322562.962962963
Buyback yield (%): 0
Retained earnings: -6460974.814814814
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.807256516377028
Rule of 40 score: 0
Financial ratios for AUAU.V — quarterly report dated 2024-09-30
Gross profit: 4105.925925925926
Capital expenditures: 0
Depreciation & amortization: -4105.925925925926
Buffett classification: The Gruesome
Stock price: 0.14074074074074072
Shares outstanding: 113505070
Market cap (USD): 15974787.629629627
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUAU.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -288778.3216783217
Net income: -590452.4475524476
Capital expenditures: 0
Operating cash flow: -239016.78321678322
Depreciation & amortization: 0
Net tangible assets: 24584009.790209793
Owner earnings: -590452.4475524476
Return on net tangible assets (%): -2.4017743752591016
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 113505070
Book value: 24584009.79020979
P/B ratio: 0.4520167609089473
Market cap (USD): 11112384.475524478
Debt to equity: 0
Current ratio: 2.418741098455751
Quick ratio: 2.418741098455751
Free cash flow (dilution-adjusted): -317622.37762237765
Buyback yield (%): 0
Retained earnings: -6689974.125874126
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.168890897458825
Rule of 40 score: 0
Financial ratios for AUAU.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: 0
Operating income: -360923.7762237762
Net income: -272692.3076923077
Capital expenditures: 0
Operating cash flow: -297461.5384615385
Depreciation & amortization: 0
Net tangible assets: 24360311.88811189
Owner earnings: -272692.3076923077
Return on net tangible assets (%): -1.1194122183032666
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 113505070
Book value: 24360311.88811189
P/B ratio: 0.4561675780903055
Market cap (USD): 11112384.475524478
Debt to equity: 0
Current ratio: 1.7047568254107892
Quick ratio: 1.7047568254107892
Free cash flow (dilution-adjusted): -346455.9440559441
Buyback yield (%): 0
Retained earnings: -6962666.433566434
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.474228837736255
Rule of 40 score: 0
Financial ratios for AUAU.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: 0
Operating income: -318937.2262773722
Net income: -450399.99999999994
Capital expenditures: 0
Operating cash flow: -112880.29197080291
Depreciation & amortization: 0
Net tangible assets: 27421354.014598537
Owner earnings: -450399.99999999994
Return on net tangible assets (%): -1.6425155364691937
Buffett classification: The Gruesome
Stock price: 0.3795620437956204
Shares outstanding: 113505070
Book value: 27421354.014598537
P/B ratio: 1.5711192207149551
Market cap (USD): 43082216.35036496
Debt to equity: 0
Current ratio: 6.703535267187173
Quick ratio: 6.703535267187173
Free cash flow (dilution-adjusted): -203651.82481751824
Buyback yield (%): 0
Retained earnings: -7718000.729927007
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1579133232934418
Rule of 40 score: 0
Financial ratios for AUAU.V — annual report dated 2025-09-30
Total revenue: 0
Gross profit: 0
Operating income: -1511128.7769784173
Net income: -1788221.582733813
Capital expenditures: 0
Operating cash flow: -1105192.0863309354
Depreciation & amortization: 0
Net tangible assets: 34201277.697841726
Owner earnings: -1788221.582733813
Return on net tangible assets (%): -5.228522742723904
Buffett classification: The Gruesome
Stock price: 0.5395683453237411
Shares outstanding: 113505070
Book value: 34201277.697841726
P/B ratio: 1.7906858143378719
Market cap (USD): 61243742.80575541
Debt to equity: 0
Current ratio: 24.52897003872818
Quick ratio: 24.52897003872818
Interest coverage ratio: -1050234.5
Free cash flow (dilution-adjusted): -1508405.0359712231
Buyback yield (%): 0
Retained earnings: -8063269.064748202
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.400230512216387
Rule of 40 score: 0
Financial ratios for AUAU.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: 0
Operating income: -528382.0143884892
Net income: -456318.70503597124
Capital expenditures: 0
Operating cash flow: -442019.4244604317
Depreciation & amortization: 0
Net tangible assets: 34201277.697841726
Owner earnings: -456318.70503597124
Return on net tangible assets (%): -1.3342153736694091
Buffett classification: The Gruesome
Stock price: 0.5395683453237411
Shares outstanding: 113505070
Book value: 34201277.697841726
P/B ratio: 1.7906858143378719
Market cap (USD): 61243742.80575541
Debt to equity: 0
Current ratio: 24.52897003872818
Quick ratio: 24.52897003872818
Interest coverage ratio: -367225.49999999994
Free cash flow (dilution-adjusted): -624494.964028777
Buyback yield (%): 0
Retained earnings: -8063269.064748202
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.538586715599153
Rule of 40 score: 0
Financial ratios for AUAU.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -666554.7445255474
Net income: -534190.510948905
Capital expenditures: 0
Operating cash flow: -417711.67883211677
Net tangible assets: 34413404.37956204
Owner earnings: -534190.510948905
Return on net tangible assets (%): -1.552274529590447
Buffett classification: The Gruesome
Stock price: 0.5985401459854014
Shares outstanding: 113505070
Book value: 34413404.379562035
P/B ratio: 1.9741534553969
Market cap (USD): 67937341.1678832
Debt to equity: 0
Current ratio: 25.21965791852962
Quick ratio: 25.21965791852962
Free cash flow (dilution-adjusted): -613645.2554744525
Buyback yield (%): 0
Retained earnings: -8715171.532846715
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9278690531922587
Rule of 40 score: 0
Financial ratios for BC8.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.46616541353383456
Shares outstanding: 728874974
Market cap (USD): 339776303.66917294
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BC8.AX — annual report dated 2022-06-30
Operating income: -2814904.1379310344
Net income: -2720624.827586207
Capital expenditures: 2207847.5862068967
Depreciation & amortization: 78808.27586206897
Net tangible assets: 54460397.24137931
Owner earnings: -4849664.137931035
Return on net tangible assets (%): -8.90493713521104
Buffett classification: The Gruesome
Stock price: 0.20689655172413793
Shares outstanding: 728874974
Book value: 54460397.241379306
P/B ratio: 2.7690161364456727
Market cap (USD): 150801718.75862068
Debt to equity: 0.0016761562998970619
Current ratio: 1.1162984488852339
Quick ratio: 1.0876271974621867
Interest coverage ratio: -162.32296679260287
Free cash flow (dilution-adjusted): -21436860.689655174
Buyback yield (%): 0.7970553076866468
Retained earnings: -6431197.24137931
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.042093273011737
Rule of 40 score: 0
Financial ratios for BC8.AX — annual report dated 2023-06-30
Operating income: -3735755.6291390727
Net income: -3178498.013245033
Capital expenditures: 538194.701986755
Depreciation & amortization: 114525.16556291391
Net tangible assets: 61903695.36423841
Owner earnings: -3602167.5496688746
Return on net tangible assets (%): -5.818986295525479
Buffett classification: The Gruesome
Stock price: 0.25165562913907286
Shares outstanding: 728874974
Book value: 61941339.73509933
P/B ratio: 2.9612774106943722
Market cap (USD): 183425490.14569536
Debt to equity: 0.05345796994877327
Current ratio: 0.4895964625298857
Quick ratio: 0.4594922453406002
Interest coverage ratio: -36.0979528889287
Free cash flow (dilution-adjusted): -17825165.562913906
Buyback yield (%): 0.2893316226650532
Retained earnings: -9037386.092715232
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.8206353740873285
Rule of 40 score: 0
Financial ratios for BC8.AX — annual report dated 2024-06-30
Total revenue: 46000
Gross profit: 46000
Operating income: -4007333.3333333335
Net income: -2538000
Capital expenditures: 1204666.6666666667
Depreciation & amortization: 14666.666666666666
Net tangible assets: 77996000
Owner earnings: -3728000
Return on net tangible assets (%): -4.779732293963793
Buffett classification: The Gruesome
Stock price: 0.20666666666666667
Shares outstanding: 728874974
Book value: 77996000
P/B ratio: 1.9313062374138845
Market cap (USD): 150634161.29333332
Debt to equity: 0.08066225618407781
Current ratio: 1.7420768368490778
Quick ratio: 1.7090594109854274
Interest coverage ratio: -2.407288746495795
COGS to revenue (%): 0
SG&A to revenue (%): 4866.666666666666
Free cash flow (dilution-adjusted): -12920666.666666666
Buyback yield (%): 0.8360210741844971
Retained earnings: -10787333.333333334
Inventory turnover: 0
Receivables turnover: 0.04267161410018553
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.061925613579847
FCF margin (%): -28088.405797101448
Rule of 40 score: -28088.405797101448
Financial ratios for BIO.B — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 722.91
Shares outstanding: 5061038
Market cap (USD): 3658674980.58
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIO.B — annual report dated 2022-12-31
Total revenue: 2802200000
Gross profit: 1567300000
Operating income: 475100000
Net income: -3627500000
Capital expenditures: 112600000
Operating cash flow: 194400000
Depreciation & amortization: 137300000
Net tangible assets: 8876652000
Owner earnings: -3602800000
Return on net tangible assets (%): -40.58737460925583
Capex to operating income (%): 23.700273626604925
Buffett classification: The Great
Stock price: 404.66
Shares outstanding: 5061038
Book value: 9615252000
P/B ratio: 0.21299489988197917
Market cap (USD): 2047999637.0800002
Debt to equity: 0.14436418307081292
Current ratio: 5.5528953346884515
Quick ratio: 4.288070503667964
Interest coverage ratio: 12.469816272965879
COGS to revenue (%): 44.06894582827778
R&D to revenue (%): 9.167796731139818
SG&A to revenue (%): 29.5410748697452
Free cash flow (dilution-adjusted): 19200000
Buyback yield (%): 10.532228428884933
Retained earnings: 9898203000
Inventory turnover: 1.716769820218096
Receivables turnover: 5.665072931091995
Capitalized R&D asset: 256900000
ROCI (R&D-adjusted, %): 4.900482375675816
FCF margin (%): 0.6851759331953465
Rule of 40 score: 0.6851759331953465
Financial ratios for BIO.B — annual report dated 2023-12-31
Total revenue: 2671200000
Gross profit: 1426900000
Operating income: 337800000
Net income: -637300000
Capital expenditures: 156500000
Operating cash flow: 374900000
Depreciation & amortization: 145900000
Net tangible assets: 8007100000
Owner earnings: -647900000
Return on net tangible assets (%): -8.091568732749685
Capex to operating income (%): 46.32918886915334
Buffett classification: The Good
Stock price: 320.65
Shares outstanding: 5061038
Book value: 8741200000
P/B ratio: 0.18565206547155996
Market cap (USD): 1622821834.6999998
Debt to equity: 0.16079028051068503
Current ratio: 5.830719204284621
Quick ratio: 4.337796480489671
Interest coverage ratio: 6.838056680161944
COGS to revenue (%): 46.582060497154835
R&D to revenue (%): 9.261755016471998
SG&A to revenue (%): 31.510182689427975
Free cash flow (dilution-adjusted): 156900000
Buyback yield (%): 26.41694798734643
Retained earnings: 9260600000
Inventory turnover: 1.594234465086483
Receivables turnover: 5.462576687116565
Capitalized R&D asset: 419523000
ROCI (R&D-adjusted, %): 3.4200233965350266
Rosenberg metric: -0.546516154145582
FCF margin (%): 5.873764600179694
Revenue growth (%): -4.6748982941974155
Rule of 40 score: 1.1988663059822784
Financial ratios for BIO.B — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 326.74
Shares outstanding: 5061038
Market cap (USD): 1653643556.1200001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIO.B — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 325.6
Shares outstanding: 5061038
Market cap (USD): 1647873972.8000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BIO.B — annual report dated 2024-12-31
Total revenue: 2566500000
Gross profit: 1378900000
Operating income: 269000000
Net income: -1844200000
Capital expenditures: 165500000
Operating cash flow: 455200000
Depreciation & amortization: 151600000
Net tangible assets: 5865200000
Owner earnings: -1858100000
Return on net tangible assets (%): -31.680079110686766
Capex to operating income (%): 61.52416356877324
Buffett classification: The Good
Stock price: 325.6
Shares outstanding: 5061038
Book value: 6569300000
P/B ratio: 0.25084468250802977
Market cap (USD): 1647873972.8000002
Debt to equity: 0.20926126071270912
Current ratio: 6.477768277041471
Quick ratio: 4.853142368533561
Interest coverage ratio: 5.5010224948875255
COGS to revenue (%): 46.27313461913111
R&D to revenue (%): 11.529320085719853
SG&A to revenue (%): 31.716345217221896
Free cash flow (dilution-adjusted): 203900000
Buyback yield (%): 12.355313777670219
Retained earnings: 7416400000
Inventory turnover: 1.5626315789473684
Receivables turnover: 5.67182320441989
Capitalized R&D asset: 546435000
ROCI (R&D-adjusted, %): 3.157630354623598
Rosenberg metric: -0.19401778496362165
FCF margin (%): 7.944671731930645
Revenue growth (%): -3.919586702605571
Rule of 40 score: 4.025085029325074
Financial ratios for BIO.B — quarterly report dated 2025-03-31
Total revenue: 585400000
Gross profit: 306000000
Operating income: 23700000
Net income: 64000000
Capital expenditures: 34400000
Operating cash flow: 129900000
Depreciation & amortization: 38100000
Net tangible assets: 5968700000
Owner earnings: 67700000
Return on net tangible assets (%): 1.1342503392698577
Capex to operating income (%): 145.1476793248945
Buffett classification: The Gruesome
Stock price: 241.99
P/E ratio: 4.784064787578125
Shares outstanding: 5061038
Book value: 6679400000
P/B ratio: 0.18335787430308112
Market cap (USD): 1224720585.6200001
Debt to equity: 0.2050333862322963
Current ratio: 5.994078168180024
Quick ratio: 4.434465061192262
Effective tax rate (%): 23.26139088729017
Interest coverage ratio: 1.975
COGS to revenue (%): 47.72804919713017
R&D to revenue (%): 12.55551759480697
SG&A to revenue (%): 35.667919371370004
Free cash flow (dilution-adjusted): 80200000
Buyback yield (%): 8.32026514426671
Retained earnings: 7480400000
Inventory turnover: 0.3536261232755347
Receivables turnover: 1.378384742170944
Capitalized R&D asset: 73500000
ROCI (R&D-adjusted, %): 0.7994457762431547
FCF margin (%): 13.700034164673728
Rule of 40 score: 13.700034164673728
Financial ratios for BIO.B — quarterly report dated 2025-06-30
Total revenue: 651600000
Gross profit: 345300000
Operating income: 77100000
Net income: 317800000
Capital expenditures: 45600000
Operating cash flow: 116500000
Depreciation & amortization: 40600000
Net tangible assets: 6150200000
Owner earnings: 312800000
Return on net tangible assets (%): 5.086013462976814
Capex to operating income (%): 59.143968871595334
Buffett classification: The Good
Stock price: 250.08
P/E ratio: 3.314993145730749
Shares outstanding: 5061038
Book value: 7128700000
P/B ratio: 0.17754490763252767
Market cap (USD): 1265664383.04
Debt to equity: 0.19730105068245263
Current ratio: 5.121333576243396
Quick ratio: 3.6660593915102933
Effective tax rate (%): 23.23671497584541
Interest coverage ratio: 6.119047619047619
COGS to revenue (%): 47.0073664825046
R&D to revenue (%): 9.284837323511356
SG&A to revenue (%): 31.87538367096378
Free cash flow (dilution-adjusted): 58900000
Buyback yield (%): 11.077186170258939
Retained earnings: 7798200000
Inventory turnover: 0.3834501752628943
Receivables turnover: 1.3866780165992765
Capitalized R&D asset: 109745000
ROCI (R&D-adjusted, %): 0.9507299870570458
Rosenberg metric: 0.5346938775510204
FCF margin (%): 9.039287906691222
Revenue growth (%): 11.308507003758114
Rule of 40 score: 20.347794910449338
Financial ratios for BIO.B — quarterly report dated 2025-09-30
Total revenue: 653000000
Gross profit: 343400000
Operating income: 63900000
Net income: -341900000
Capital expenditures: 31700000
Operating cash flow: 120900000
Depreciation & amortization: 44200000
Net tangible assets: 5769700000
Owner earnings: -329400000
Return on net tangible assets (%): -5.709135656966566
Capex to operating income (%): 49.60876369327074
Buffett classification: The Good
Stock price: 284.88
P/E ratio: 36.135050261654136
Shares outstanding: 5061038
Book value: 6736800000
P/B ratio: 0.214016818881368
Market cap (USD): 1441788505.44
Debt to equity: 0.20711613822586392
Current ratio: 5.441317250622248
Quick ratio: 3.94179590273789
Interest coverage ratio: 5.195121951219512
COGS to revenue (%): 47.411944869831544
R&D to revenue (%): 10.918836140888208
SG&A to revenue (%): 31.669218989280246
Free cash flow (dilution-adjusted): 74300000
Buyback yield (%): 3.703733231227528
Retained earnings: 7456300000
Inventory turnover: 0.3953013278855976
Receivables turnover: 1.4052076608564665
Capitalized R&D asset: 136090000
ROCI (R&D-adjusted, %): 0.7171353824859286
Rosenberg metric: -0.03140495867768595
FCF margin (%): 11.378254211332314
Revenue growth (%): 0.21485573971761818
Rule of 40 score: 11.593109951049932
Financial ratios for BIO.B — annual report dated 2025-12-31
Total revenue: 2583200000
Gross profit: 1339900000
Operating income: 218600000
Net income: 759900000
Capital expenditures: 157500000
Operating cash flow: 532200000
Depreciation & amortization: 165400000
Net tangible assets: 6699500000
Owner earnings: 767800000
Return on net tangible assets (%): 11.460556757967012
Capex to operating income (%): 72.04940530649588
Buffett classification: The Good
Stock price: 310.7
P/E ratio: 2.0693045224371627
Shares outstanding: 5061038
Book value: 7453600000
P/B ratio: 0.21096711744660296
Market cap (USD): 1572464506.6
Debt to equity: 0.1859638295588709
Current ratio: 5.621276595744681
Quick ratio: 4.188588007736944
Effective tax rate (%): 23.666499246609742
Interest coverage ratio: 4.461224489795918
COGS to revenue (%): 48.13022607618458
R&D to revenue (%): 10.66893775162589
SG&A to revenue (%): 32.68426757510065
Free cash flow (dilution-adjusted): 316600000
Buyback yield (%): 18.792157073162393
Retained earnings: 8176300000
Inventory turnover: 1.6785473201026055
Receivables turnover: 5.608336951801998
Capitalized R&D asset: 555495000
ROCI (R&D-adjusted, %): 2.0841586202662676
Rosenberg metric: -0.1318012842176411
FCF margin (%): 12.256116444719728
Revenue growth (%): 0.650691603350867
Rule of 40 score: 12.906808048070594
Financial ratios for BIO.B — quarterly report dated 2025-12-31
Total revenue: 693200000
Gross profit: 345200000
Operating income: 53900000
Net income: 720000000
Capital expenditures: 45800000
Operating cash flow: 164900000
Depreciation & amortization: 42500000
Net tangible assets: 6699500000
Owner earnings: 716700000
Return on net tangible assets (%): 10.69781326964699
Capex to operating income (%): 84.97217068645641
Buffett classification: The Gruesome
Stock price: 310.7
P/E ratio: 2.0693045224371627
Shares outstanding: 5061038
Book value: 7453600000
P/B ratio: 0.21096711744660296
Market cap (USD): 1572464506.6
Debt to equity: 0.1859638295588709
Current ratio: 5.621276595744681
Quick ratio: 4.188588007736944
Effective tax rate (%): 22.51399052948773
Interest coverage ratio: 4.454545454545454
COGS to revenue (%): 50.201961915753024
R&D to revenue (%): 10.141373341027121
SG&A to revenue (%): 31.881130986728216
Free cash flow (dilution-adjusted): 103200000
Buyback yield (%): 0
Retained earnings: 8176300000
Inventory turnover: 0.46982584042122316
Receivables turnover: 1.5049934867564048
Capitalized R&D asset: 138036000
ROCI (R&D-adjusted, %): 0.5573241745195441
Rosenberg metric: 0.025245441795231416
FCF margin (%): 14.88747836122331
Revenue growth (%): 6.1562021439509955
Rule of 40 score: 21.043680505174308
Financial ratios for BTOG — annual report dated 2021-06-30
Total revenue: 0
Gross profit: 0
Operating income: -2592705.223880597
Net income: -34036954.47761194
Capital expenditures: 0
Operating cash flow: -7752076.119402984
Depreciation & amortization: 0
Net tangible assets: -2404219.4029850746
Owner earnings: -34036954.47761194
Buffett classification: The Gruesome
Stock price: 2826
Shares outstanding: 2682355
Book value: -1208946.2686567195
Market cap (USD): 7580335230
Debt to equity: -0.8024750800623194
Current ratio: 0.840413174131151
Quick ratio: 0.8344853174738945
Interest coverage ratio: -22.263822669947707
Free cash flow (dilution-adjusted): -9161906.716417909
Buyback yield (%): 0
Retained earnings: -28787029.850746267
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -159.47521638384677
Rule of 40 score: 0
Financial ratios for BTOG — annual report dated 2022-06-30
Total revenue: 138382.01438848922
Gross profit: -151822.30215827338
Operating income: -4358466.18705036
Net income: 2330496.402877698
Capital expenditures: 5973304.316546763
Operating cash flow: -10241249.64028777
Depreciation & amortization: 199110.07194244605
Net tangible assets: 24931623.021582734
Owner earnings: -3443697.841726619
Return on net tangible assets (%): -13.812569838495827
Buffett classification: The Gruesome
Stock price: 783
P/E ratio: 901.217424067494
Shares outstanding: 2682355
Book value: 24931623.021582734
P/B ratio: 84.2417664979866
Market cap (USD): 2100283965
Debt to equity: 0
Current ratio: 79.77115558992959
Quick ratio: 79.77115558992959
Interest coverage ratio: -111.90623787797625
COGS to revenue (%): 209.71245275563942
SG&A to revenue (%): 3039.877619560075
Free cash flow (dilution-adjusted): -17381522.302158274
Buyback yield (%): 0
Retained earnings: -25887355.395683456
Receivables turnover: 0.04351020454326964
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.481678522402397
FCF margin (%): -12560.535687363204
Rule of 40 score: -12560.535687363204
Financial ratios for BTOG — annual report dated 2023-06-30
Total revenue: 4603743.382352941
Gross profit: -3357006.617647059
Operating income: -7956817.647058823
Net income: -20747317.647058822
Capital expenditures: 84583.08823529411
Operating cash flow: -4971755.147058823
Depreciation & amortization: 3942613.970588235
Net tangible assets: 7544905.147058823
Owner earnings: -16889286.764705878
Return on net tangible assets (%): -223.8502199234368
Buffett classification: The Gruesome
Stock price: 122.58
Shares outstanding: 2682355
Book value: 7544905.147058823
P/B ratio: 43.579484366105646
Market cap (USD): 328803075.9
Debt to equity: 0.202298473521916
Current ratio: 1.3803471222847872
Quick ratio: 1.3803471222847872
Interest coverage ratio: -47.5919710083738
COGS to revenue (%): 172.91906474446705
SG&A to revenue (%): 47.62561349132283
Free cash flow (dilution-adjusted): -5105802.205882353
Buyback yield (%): 0
Retained earnings: -47205717.64705882
Receivables turnover: 13.373484531326094
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -100.68731953198369
FCF margin (%): -110.90544762885574
Revenue growth (%): 3226.8365131819364
Rule of 40 score: 3115.9310655530808
Financial ratios for BTOG — annual report dated 2024-06-30
Total revenue: 2123883.8235294116
Gross profit: -695001.4705882353
Operating income: -4387299.264705882
Net income: -12890916.911764706
Capital expenditures: 0
Operating cash flow: -5830319.117647058
Depreciation & amortization: 662454.4117647058
Net tangible assets: 1222532.3529411764
Owner earnings: -12228462.5
Return on net tangible assets (%): -1000.2567597152488
Buffett classification: The Gruesome
Stock price: 172.8
Shares outstanding: 2682355
Book value: 668811.0294117648
P/B ratio: 693.0372311707672
Market cap (USD): 463510944.00000006
Debt to equity: 5.677338956422886
Current ratio: 2.6833756829120454
Quick ratio: 2.6833756829120454
Interest coverage ratio: -11.986963806431913
COGS to revenue (%): 132.72313969759895
SG&A to revenue (%): 134.65678512104282
Free cash flow (dilution-adjusted): -5884164.705882353
Buyback yield (%): 0
Retained earnings: -60096634.558823526
Receivables turnover: 0.9382114787649766
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -142.28258705281294
FCF margin (%): -277.0473902901247
Revenue growth (%): -53.86615527549432
Rule of 40 score: -330.9135455656191
Financial ratios for BTOG — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -832457.3529411764
Buffett classification: The Gruesome
Stock price: 58.8
Shares outstanding: 2682355
Book value: -1396283.0882352944
Market cap (USD): 157722474
Debt to equity: -3.0001242795341616
Current ratio: 2.040145418718614
Quick ratio: 2.040145418718614
Buyback yield (%): 0
Retained earnings: -62159377.94117647
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBY.AX — annual report dated 2021-06-30
Operating income: -1311952.6315789472
Net income: -986412.0300751879
Capital expenditures: 1298.4962406015036
Depreciation & amortization: 17163.15789473684
Net tangible assets: 6716002.255639098
Owner earnings: -970547.3684210526
Return on net tangible assets (%): -14.451266266418115
Buffett classification: The Gruesome
Stock price: 0.06766917293233082
Shares outstanding: 279698164
Book value: 8772963.157894736
P/B ratio: 2.157417407086588
Market cap (USD): 18926943.42857143
Debt to equity: 0.004489871093185223
Current ratio: 4.8657615833193715
Quick ratio: 4.8657615833193715
Free cash flow (dilution-adjusted): -1403561.6541353383
Buyback yield (%): 0
Retained earnings: -3500049.6240601502
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.897357974761787
Rule of 40 score: 0
Financial ratios for CBY.AX — annual report dated 2022-06-30
Operating income: -1343290.3448275863
Net income: -1238115.1724137932
Capital expenditures: 5006.896551724138
Depreciation & amortization: 19402.068965517243
Net tangible assets: 7746048.275862069
Owner earnings: -1223720
Return on net tangible assets (%): -15.797990877662201
Buffett classification: The Gruesome
Stock price: 0.027586206896551727
Shares outstanding: 279698164
Book value: 7803846.8965517245
P/B ratio: 0.9887189642455737
Market cap (USD): 7715811.420689656
Debt to equity: 0.0029795207986724145
Current ratio: 1.8403347430766464
Quick ratio: 1.8403347430766464
Free cash flow (dilution-adjusted): -1017288.275862069
Buyback yield (%): 0
Retained earnings: -4374881.379310345
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.162801615748776
Rule of 40 score: 0
Financial ratios for CBY.AX — annual report dated 2023-06-30
Operating income: -785519.8675496689
Net income: -541598.0132450331
Capital expenditures: 141717.88079470198
Depreciation & amortization: 17190.066225165563
Net tangible assets: 7493987.417218543
Owner earnings: -666125.8278145695
Return on net tangible assets (%): -8.888803659905367
Buffett classification: The Gruesome
Stock price: 0.013245033112582781
Shares outstanding: 279698164
Book value: 7493987.417218543
P/B ratio: 0.4943444974562831
Market cap (USD): 3704611.4437086093
Debt to equity: 0.0012275624759133614
Current ratio: 1.91427241552159
Quick ratio: 1.91427241552159
Free cash flow (dilution-adjusted): -718646.357615894
Buyback yield (%): 0
Retained earnings: -4704416.556291391
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.45655566406646
Rule of 40 score: 0
Financial ratios for CBY.AX — annual report dated 2024-06-30
Operating income: -829756
Net income: -470118
Capital expenditures: 4159.333333333333
Depreciation & amortization: 12359.333333333334
Net tangible assets: 7496126.666666667
Owner earnings: -461918
Return on net tangible assets (%): -6.16208904331926
Buffett classification: The Gruesome
Stock price: 0.03333333333333333
Shares outstanding: 279698164
Book value: 7496126.666666667
P/B ratio: 1.2437452764494374
Market cap (USD): 9323272.133333333
Debt to equity: 0.0355739275127866
Current ratio: 1.1188385980209532
Quick ratio: 1.1188385980209532
Interest coverage ratio: -189.90448581019226
Free cash flow (dilution-adjusted): -380029.3333333333
Buyback yield (%): 0
Retained earnings: -5146566.666666667
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.03412044079247
Rule of 40 score: 0
Financial ratios for CHL.L — annual report dated 2022-03-31
Total revenue: 83651.31578947368
Gross profit: 83651.31578947368
Operating income: -1255434.2105263157
Net income: 1953397.3684210526
Capital expenditures: 17519.736842105263
Operating cash flow: -2952426.3157894737
Depreciation & amortization: 629993.4210526316
Net tangible assets: 1429219.7368421052
Owner earnings: 2565871.052631579
Return on net tangible assets (%): 179.52950036226983
Buffett classification: The Gruesome
Stock price: 0.011842105263157895
P/E ratio: 0.09020476672895132
Shares outstanding: 14879597
Book value: 5722196.052631579
P/B ratio: 0.030793379382087618
Market cap (USD): 176205.75394736842
Debt to equity: 0.6009180777806827
Current ratio: 2.7448575930787986
Quick ratio: 2.7448575930787986
Interest coverage ratio: -208.73550645373
COGS to revenue (%): 0
SG&A to revenue (%): 1600.7943373967755
Free cash flow (dilution-adjusted): -2993418.4210526315
Buyback yield (%): 0
Retained earnings: -1838784.2105263157
Receivables turnover: 0.1214090515866726
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.471207812659486
FCF margin (%): -3578.4475029492723
Rule of 40 score: -3578.4475029492723
Financial ratios for CHL.L — annual report dated 2023-03-31
Total revenue: 0
Gross profit: 0
Operating income: -1475544.4444444443
Net income: -3148318.518518518
Capital expenditures: 59517.28395061728
Operating cash flow: -2258611.111111111
Depreciation & amortization: 538061.7283950617
Net tangible assets: 2225796.296296296
Owner earnings: -2669774.0740740737
Return on net tangible assets (%): -119.94691870574825
Buffett classification: The Gruesome
Stock price: 0.004567901234567901
Shares outstanding: 14879597
Book value: 2225796.2962962966
P/B ratio: 0.030536725044997066
Market cap (USD): 67968.52950617284
Debt to equity: 0
Current ratio: 20.785804062648175
Quick ratio: 20.785804062648175
Free cash flow (dilution-adjusted): -2333381.4814814813
Buyback yield (%): 0
Retained earnings: -3617293.8271604935
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.73159700561447
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CHL.L — annual report dated 2024-03-31
Total revenue: 17639.24050632911
Gross profit: 17639.24050632911
Operating income: -1855716.4556962023
Net income: -1780863.2911392404
Capital expenditures: 1618.987341772152
Operating cash flow: -1298860.759493671
Depreciation & amortization: 306245.56962025317
Net tangible assets: 495588.6075949367
Owner earnings: -1476236.7088607594
Return on net tangible assets (%): -297.8754326143315
Buffett classification: The Gruesome
Stock price: 0.0026582278481012654
Shares outstanding: 14879597
Book value: 495588.60759493674
P/B ratio: 0.07981087238036855
Market cap (USD): 39553.359113924045
Debt to equity: 0
Current ratio: 2.884848134721761
Quick ratio: 2.884848134721761
Interest coverage ratio: -1435.8628795298725
COGS to revenue (%): 0
SG&A to revenue (%): 10620.38751345533
Free cash flow (dilution-adjusted): -1293167.0886075948
Buyback yield (%): 0
Retained earnings: -5197308.860759494
Receivables turnover: 1.2522465851905102
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -374.4469560553235
FCF margin (%): -7331.19483315393
Rule of 40 score: -7331.19483315393